Sectra Signs Enterprise Imaging Contract with One of the Larger Multi-Regional Healthcare Systems in the United States

nternational medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide Sectra One Cloud, its enterprise imaging cloud subscription service for diagnostic imaging, to a US-based health system serving a multi-million strong patient community.

Sectra will, as the sole imaging IT provider oversee and deliver the end-to-end infrastructure through a turnkey, fully managed SaaS agreement. Expanding on Sectra’s previously implemented solution for Ophthalmology this enterprise imaging solution will initially be leveraged by the health system’s Radiology service teams and over time into additional imaging service lines including Pathology, Cardiology and Orthopaedics. The cloud solution will be operated in Microsoft Azure as part of a sub-contract agreement with Microsoft managed by Sectra.

“Health systems are under tremendous pressure to maintain patient excellence while balancing growing financial and staffing concerns,” shared Isaac Zaworski, the President of Sectra, Inc. “Regardless of size or infrastructure challenges, Sectra is focused on driving down the costs and complexity of traditional on-premise solutions with highly scalable, high-performance enterprise imaging solutions as a service. We are thrilled for the opportunity to help this health leader execute a long-term multi-departmental imaging strategy as they focus on growing quality and sustainability in their health system.”

The contracted order value for the implementation and use of subscription service until 2033 initially amounts to 227 million dollars, if the full term of the contract is realized, and does not include   expansion plans into additional imaging service lines including, Pathology, Cardiology and Orthopaedics. The agreement was signed in June 2023 and is recognized in order bookings for the first quarter of the 2023/2024 fiscal year.

Sectra One Cloud

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version